Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from The microbiome in post-acute infection syndrome (PAIS). Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/s41579-022-00846-2
10.1038/s41579-022-00846-2 · External reference
WHO clinical case definition working group on post-COVID-19 condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus
10.1016/s1473-3099(21)00703-9 · 2022 · External reference
10.1038/s41591-022-01810-6
10.1038/s41591-022-01810-6 · External reference
How “long covid” is shedding light on postviral syndromes
10.1136/bmj.o2188 · 2022 · External reference
Characteristics and management of postpolio syndrome
10.1001/jama.284.4.412 · 2000 · External reference
10.1016/j.molmed.2021.06.002
10.1016/j.molmed.2021.06.002 · External reference
A natural history of disease framework for improving the prevention, management, and research on post-viral fatigue syndrome and other forms of myalgic encephalomyelitis/chronic fatigue syndrome
10.3389/fmed.2021.688159 · 2021 · External reference
Prevalence of post-chikungunya infection chronic inflammatory arthritis: a systematic review and meta-analysis
10.1002/acr.22900 · 2016 · External reference
Prevalence of irritable bowel syndrome and chronic fatigue 10 years after giardia infection
10.1016/j.cgh.2018.01.022 · 2018 · External reference
An update on ocular complications of Ebola virus disease
10.1097/icu.0000000000000426 · 2017 · External reference
RECOVER Mechanistic Pathway Task Force. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
10.7554/elife.86002 · 2023 · External reference
10.1038/nm.4142
10.1038/nm.4142 · External reference
10.1371/journal.pbio.1002533
10.1371/journal.pbio.1002533 · External reference
10.1111/imm.13117
10.1111/imm.13117 · External reference
10.1136/bmj.j5145
10.1136/bmj.j5145 · External reference
The role of the microbiota in infectious diseases
10.1038/s41564-018-0278-4 · 2019 · External reference
10.1038/nrmicro.2015.25
10.1038/nrmicro.2015.25 · External reference
10.1016/j.coviro.2019.05.002
10.1016/j.coviro.2019.05.002 · External reference
The complex interactions between rotavirus and the gut microbiota
10.3389/fcimb.2020.586751 · 2020 · External reference
10.1016/j.immuni.2022.04.007
10.1016/j.immuni.2022.04.007 · External reference
10.1111/prd.12425
10.1111/prd.12425 · External reference
Regulation of staphylococcus aureus virulence
10.1128/microbiolspec.gpp3-0031-2018 · 2019 · External reference
Emergence of nosocomial associated opportunistic pathogens in the gut microbiome after antibiotic treatment
10.1186/s13756-021-00903-0 · 2021 · External reference
10.1038/s41422-020-0332-7
10.1038/s41422-020-0332-7 · External reference
10.1136/gutjnl-2021-325989
10.1136/gutjnl-2021-325989 · External reference
The gut microbiota in anxiety and depression - A systematic review
10.1016/j.cpr.2020.101943 · 2021 · External reference
Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization
10.1038/s41522-021-00232-5 · 2021 · External reference
Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases
10.1186/s12866-022-02686-9 · 2022 · External reference
10.1053/j.gastro.2020.05.048
10.1053/j.gastro.2020.05.048 · External reference
The nasopharyngeal microbiome in COVID-19
10.1080/22221751.2023.2165970 · 2023 · External reference
Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza
10.1093/cid/ciaa709 · 2020 · External reference
Respiratory tract infections and gut microbiome modifications: a systematic review
10.1371/journal.pone.0262057 · 2022 · External reference
Gut microbiome changes associated with HIV infection and sexual orientation
10.3389/fcimb.2020.00434 · 2020 · External reference
10.3748/wjg.v27.i33.5488
10.3748/wjg.v27.i33.5488 · External reference
Microbiota and tuberculosis: a potential role of probiotics, and postbiotics
2021 · External reference
Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production
10.1016/j.celrep.2020.02.013 · 2020 · External reference
Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis
10.1186/s40168-017-0386-z · 2018 · External reference
Respiratory viral infection alters the gut microbiota by inducing inappetence
10.1128/mbio.03236-19 · 2020 · External reference
Abnormal blood bacteriome, gut dysbiosis, and progression to severe dengue disease
10.3389/fcimb.2022.890817 · 2022 · External reference
Characterization of oral and gut microbiome and plasma metabolomics in COVID-19 patients after 1-year follow-up
2022 · External reference
Linking the gut microbiota to persistent symptoms in survivors of COVID-19 after discharge
10.1007/s12275-021-1206-5 · 2021 · External reference
Six-month follow-up of gut microbiota richness in patients with COVID-19
10.1136/gutjnl-2021-324090 · 2022 · External reference
Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS
10.1016/j.chom.2023.01.004 · 2023 · External reference
Multi-’omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients
10.1016/j.chom.2023.01.001 · 2023 · External reference
Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome
10.1186/s40168-017-0261-y · 2017 · External reference
A distinct microbiome signature in posttreatment lyme disease patients
10.1128/mbio.02310-20 · 2020 · External reference
The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort
10.1080/19490976.2021.1926840 · 2021 · External reference
Potential implications of SARS-CoV-2 oral infection in the host microbiota
10.1080/20002297.2020.1853451 · 2020 · External reference
Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID
10.1172/jci.insight.152346 · 2021 · External reference
Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling
10.1172/jci.insight.164813 · 2022 · External reference
Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England
10.1016/j.jinf.2021.12.047 · 2022 · External reference
The gut microbiome in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS)
10.3389/fimmu.2021.628741 · 2021 · External reference
A multicenter virome analysis of blood, feces, and saliva in myalgic encephalomyelitis/chronic fatigue syndrome
10.1002/jmv.28993 · 2023 · External reference
Myalgic encephalomyelitis/chronic fatigue syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity
10.3389/fped.2018.00373 · 2018 · External reference
Persistence of Ebola virus in semen among Ebola virus disease survivors in Sierra Leone: a cohort study of frequency, duration, and risk factors
10.1371/journal.pmed.1003273 · 2021 · External reference
Zika virus persistence in the central nervous system and lymph nodes of rhesus monkeys
2017 · External reference
10.1523/jneurosci.1740-17.2018
10.1523/jneurosci.1740-17.2018 · External reference
10.1016/s2468-1253(20)30083-2
10.1016/s2468-1253(20)30083-2 · External reference
Long-term gastrointestinal outcomes of COVID-19
10.1038/s41467-023-36223-7 · 2023 · External reference
The role of enterovirus in chronic fatigue syndrome
10.1136/jcp.2004.020255 · 2005 · External reference
Testing of bacteria isolated from HIV/AIDS patients in experimental models
2006 · External reference
Confirmation of HIV-like sequences in respiratory tract bacteria of Cambodian and Kenyan HIV-positive pediatric patients
10.12659/msm.881449 · 2011 · External reference
Investigation of Long COVID prevalence and its relationship to epstein-barr virus reactivation
2021 · External reference
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality
10.1007/s00134-022-06716-y · 2022 · External reference
Distinguishing features of Long COVID identified through immune profiling
2022 · External reference
10.1016/j.intimp.2021.108125
10.1016/j.intimp.2021.108125 · External reference
Could long COVID be linked to herpes viruses? Early data offer a hint
10.1038/d41586-022-02296-5 · 2022 · External reference
10.1007/s00296-022-05146-9
10.1007/s00296-022-05146-9 · External reference
Treatment of long-Haul COVID patients with off-label acyclovir
10.7759/cureus.37926 · 2023 · External reference
10.1126/science.abi6087
10.1126/science.abi6087 · External reference
10.1016/j.immuni.2017.05.011
10.1016/j.immuni.2017.05.011 · External reference
The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: a hypothesis and review of literature
10.3389/fcimb.2022.983089 · 2022 · External reference
The biological basis of chronic fatigue: neuroinflammation and innate immunity
10.1097/wco.0000000000000817 · 2020 · External reference
10.1038/s41586-020-2387-5
10.1038/s41586-020-2387-5 · External reference
Molecular mechanisms of neuroinflammation in ME/CFS and long COVID to sustain disease and promote relapses
10.3389/fneur.2022.877772 · 2022 · External reference
10.1016/j.cell.2023.01.039
10.1016/j.cell.2023.01.039 · External reference
10.1016/j.heliyon.2021.e07548
10.1016/j.heliyon.2021.e07548 · External reference
Gut microbiota dynamics in relation to long-COVID-19 syndrome: role of probiotics to combat psychiatric complications
10.3390/metabo12100912 · 2022 · External reference
Could SARS-CoV-2 have bacteriophage behavior or induce the activity of other bacteriophages?
10.3390/vaccines10050708 · 2022 · External reference
Gender differences in chronic fatigue syndrome
2016 · External reference
10.1016/j.cmi.2021.11.002
10.1016/j.cmi.2021.11.002 · External reference
The underlying sex differences in neuroendocrine adaptations relevant to Myalgic Encephalomyelitis Chronic Fatigue Syndrome
10.1016/j.yfrne.2022.100995 · 2022 · External reference
10.1038/s41591-022-01909-w
10.1038/s41591-022-01909-w · External reference
The influence of a blend of probiotic lactobacillus and prebiotic inulin on the duration and severity of symptoms among individuals with covid-19
2021 · External reference
Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial
10.1080/19490976.2021.2018899 · 2022 · External reference
Dietary recommendations for Post-COVID-19 Ssyndrome
10.3390/nu14061305 · 2022 · External reference
Nutritional modulation of gut microbiota alleviates severe gastrointestinal symptoms in a patient with post-acute COVID-19 syndrome
10.1128/mbio.03801-21 · 2022 · External reference
The emerging role of gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): current evidence and potential therapeutic applications
10.3390/jcm10215077 · 2021 · External reference
A systematic review of probiotic interventions for gastrointestinal symptoms and irritable bowel syndrome in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)
10.1007/s12602-018-9397-8 · 2018 · External reference
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
10.1136/gutjnl-2018-316818 · 2018 · External reference
10.1016/j.humic.2019.100061
10.1016/j.humic.2019.100061 · External reference
Phage Therapy in the Postantibiotic Era
10.1128/cmr.00066-18 · 2019 · External reference
Bacteriophage cocktails in the post-COVID rehabilitation
10.3390/v14122614 · 2022 · External reference
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up
2022 · External reference
10.2337/dc20-2257
10.2337/dc20-2257 · External reference
10.1016/j.isci.2020.101425
10.1016/j.isci.2020.101425 · External reference
